Related-Party Distributor Concentration
One of the largest distributors showing 77% UP concentration is a related-party (promoter entity) without management proactively disclosing this material related-party relationship.
QLINEBIOTECH / Q4-FY26 / risks
Keep the risk register visible.
Qlinebiotech · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
Government Business Concentration
65% of revenue is B2G (government) which creates tender-dependent, cyclic revenue patterns. FY25 instrument revenue was 'exceptional' due to government orders while FY26 saw degrowth in instrument segment.
Working Capital Efficiency
Receivable days stood at 134 days in FY26. Management targets 90-120 days going forward but provided no specific timeline for achieving this improvement.
Corporate Guarantees for Related Parties
Company had extended corporate guarantees on behalf of related parties and associate entities. Management confirmed they are 'in the process' of closing these but could not provide timelines when pressed by analysts.